Facilitating access of AIDS drugs while maintaining strong patent protection.
نویسنده
چکیده
The AIDS pandemic has thrust the subject of patent protection into the spotlight, a spotlight that has attracted the attention of broad audience including interested parties from the political, legal, and medical communities. Can the United States' scheme of strong patent protection for pharmaceutical products withstand the increased attention?
منابع مشابه
Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) – A Strategic Option for India
The current HIV/AIDS scenario in India is quite grim with an estimated 2.4 million people living with HIV/AIDS (PLHA) in 2008, just behind South Africa and Nigeria. The anti-retroviral drugs (ARVs) remain the main stay of global HIV/AIDS treatment. Over 30 ARVs (single and FDCs) available under six categories viz., NRTIs (nucleoside reverse transcriptase inhibitors), NNRTIs (non-nucleoside reve...
متن کاملDo patents for antiretroviral drugs constrain access to AIDS treatment in Africa?
Public attention and debate recently have focused on access to treatment of acquired immunodeficiency syndrome (AIDS) in poor, severely affected countries, such as those in Africa. Whether patents on antiretroviral drugs in Africa are impeding access to lifesaving treatment for the 25 million Africans with human immunodeficiency virus infection is unknown. We studied the patent statuses of 15 a...
متن کاملTechnology Development Through Pooling ARV Drug Patents: A Vision from China
Unaffordable prices still bar the end-users in China from accessing ARV drugs. Patent protection of ARV drugs has dramatically limited the availability of these lifesaving drugs to AIDS patients in China.The way Chinese government can go to breakthrough the ARV drug patents are suggested as:Make more generic drugs available through compulsory licensing, impartment from other countries or buildi...
متن کاملAn exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in India.
Access to affordable drugs for the treatment of HIV/AIDS and other diseases is increasingly challenging in many developing countries such as Brazil, South Africa, and India. These challenges are in part the result of strengthened patent laws mandated by the 1994 Trade-Related Aspects of Intellectual Property Rights (TRIPS) treaty. However, there are underutilized instruments within TRIPS that g...
متن کاملAIDS and TRIPS Pharmaceutical Patents, Generic Drugs and Public Health Under The TRIPS Agreement
The signing of the TRIPS agreement in 1994 heralded the world-wide enforcement of the type of intellectual property rights regime that had been established in the most developed countries. The arrival of this type of regime, which provides enlarged and powerful protection to patent-holders, coincided with the global development of the AIDS epidemic. This generated a series of new problems, part...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Duke law and technology review
دوره شماره
صفحات -
تاریخ انتشار 2001